TP53BP2 and acute leukemia: Our findings that knockdown of ASPP2 expression in both established and primary leukemic cell lines inhibits chemotherapy-induced apoptosis (Figures 2 and 3) demonstrates the functional importance of ASPP2 in acute leukemia response to therapy.